Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jan-12 7:23 PM View:  | Seattle Genetics Inc. (SGEN) | 30-Dec-11 | Exercise (in-the money or at-the-money) | 49,563 | $6.25 | $309,769.00 | 12% 400.9K to 450.46K | |
| 03-Jan-12 6:04 PM View: | Adolor Corp. (ADLR) | 19-Dec-11 | Disposition (change in control) | 12,679 | $4.25 | $53,885.80 | (100%) 12.68K to 0 | |
| 04-Nov-11 8:31 PM View: | Trimeris Inc. (GEVA) | 02-Nov-11 | Grant | 174,716 | -- | -- | 545% 32.08K to 206.8K | |
| 03-Aug-11 4:53 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 02-Aug-11 | Market Sale | 507 | $17.25 | $8,744.74 | (< 1%) 67.83K to 67.32K | (100%) |
| 03-Aug-11 4:53 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 01-Aug-11 | Market Sale | 8,145 | $18.04 | $146,896.00 | (11%) 75.97K to 67.83K | (91%) |
| 13-May-11 5:52 PM View: | ViroPharma Inc. (VPHM) | 10-May-11 | Disposition (other) | 83,119 | -- | -- | (98%) 84.42K to 1.31K | |
| 29-Oct-10 5:34 PM View: | Adolor Corp. (ADLR) | 29-Oct-10 | Market Sale | 60 | $1.18 | $70.98 | (< 1%) 12.74K to 12.68K | (314%) |
| 29-Oct-10 5:34 PM View: | Adolor Corp. (ADLR) | 28-Oct-10 | Market Sale | 142 | $1.19 | $168.75 | (1%) 12.88K to 12.74K | (313%) |
| 29-Oct-10 5:34 PM View: | Adolor Corp. (ADLR) | 27-Oct-10 | Market Sale | 128 | $1.29 | $165.55 | (< 1%) 13.01K to 12.88K | (279%) |
| 23-Sep-10 5:43 PM View: | Incyte Corp (INCY) | 23-Sep-10 | Market Sale | 3,820 | $14.86 | $56,768.30 | (2%) 163.56K to 159.74K | (495%) |
| 23-Sep-10 5:43 PM View: | Incyte Corp (INCY) | 22-Sep-10 | Market Sale | 4,829 | $14.71 | $71,043.30 | (3%) 168.39K to 163.56K | (501%) |
| 23-Sep-10 5:43 PM View: | Incyte Corp (INCY) | 21-Sep-10 | Market Sale | 12,974 | $14.94 | $193,870.00 | (7%) 181.36K to 168.39K | (491%) |
| 11-Aug-10 5:24 PM View: | Incyte Corp (INCY) | 10-Aug-10 | Market Sale | 1,877 | $14.00 | $26,275.50 | (1%) 183.24K to 181.36K | (531%) |
| 11-Aug-10 5:24 PM View: | Incyte Corp (INCY) | 09-Aug-10 | Market Sale | 6,670 | $14.08 | $93,938.00 | (4%) 189.91K to 183.24K | (527%) |
| 28-Sep-09 8:45 PM View: | Incyte Corp (INCY) | 24-Sep-09 | Grant | 50,294 | $6.75 | $339,484.00 | 36% 139.62K to 189.91K | 1209% |
| 26-May-09 4:17 PM View: | ViroPharma Inc. (VPHM) | 21-May-09 | Market Purchase | 86 | $6.08 | $523.21 | < 1% 84.34K to 84.42K | 726% |
| 22-May-09 4:29 PM View: | Genomic Health Inc. (GHDX) | 21-May-09 | Market Purchase | 10 | $17.82 | $178.24 | < 1% 194.15K to 194.16K | 374% |
| 20-May-09 5:34 PM View: | Seattle Genetics Inc. (SGEN) | 20-May-09 | Market Purchase | 35,253 | $9.72 | $342,659.00 | 10% 365.64K to 400.9K | 619% |
| 22-May-09 4:29 PM View: | Genomic Health Inc. (GHDX) | 20-May-09 | Market Purchase | 80 | $17.99 | $1,438.90 | < 1% 194.07K to 194.15K | 370% |
| 20-May-09 5:30 PM View: | ViroPharma Inc. (VPHM) | 19-May-09 | Market Purchase | 183 | $5.99 | $1,096.68 | < 1% 84.16K to 84.34K | 738% |
| 20-May-09 5:30 PM View: | ViroPharma Inc. (VPHM) | 18-May-09 | Market Purchase | 199 | $5.97 | $1,187.07 | < 1% 83.96K to 84.16K | 742% |
| 15-May-09 4:27 PM View: | ViroPharma Inc. (VPHM) | 13-May-09 | Market Purchase | 996 | $5.46 | $5,435.88 | 1% 82.96K to 83.96K | 821% |
| 11-May-09 5:00 PM View: | ViroPharma Inc. (VPHM) | 11-May-09 | Market Purchase | 219 | $5.86 | $1,282.99 | < 1% 82.74K to 82.96K | 758% |
| 11-May-09 5:36 PM View: | Genomic Health Inc. (GHDX) | 11-May-09 | Market Purchase | 117 | $19.48 | $2,279.12 | < 1% 193.95K to 194.07K | 334% |
| 11-May-09 5:00 PM View: | ViroPharma Inc. (VPHM) | 08-May-09 | Market Purchase | 298 | $5.92 | $1,765.29 | < 1% 82.44K to 82.74K | 748% |
| 11-May-09 5:36 PM View: | Genomic Health Inc. (GHDX) | 08-May-09 | Market Purchase | 67 | $19.67 | $1,317.94 | < 1% 193.89K to 193.95K | 337% |
| 11-May-09 5:00 PM View: | ViroPharma Inc. (VPHM) | 07-May-09 | Market Purchase | 494 | $5.72 | $2,826.79 | < 1% 81.95K to 82.44K | 778% |
| 11-May-09 5:36 PM View: | Genomic Health Inc. (GHDX) | 07-May-09 | Market Purchase | 128 | $19.54 | $2,501.06 | < 1% 193.76K to 193.89K | 340% |
| 05-Mar-09 6:16 PM View: | Incyte Corp (INCY) | 05-Mar-09 | Market Purchase | 64 | $2.16 | $138.08 | < 1% 139.55K to 139.62K | 3239% |
| 05-Mar-09 6:16 PM View: | Incyte Corp (INCY) | 03-Mar-09 | Market Purchase | 98 | $2.14 | $209.88 | < 1% 139.45K to 139.55K | 3263% |
| 02-Mar-09 7:34 PM View: | Incyte Corp (INCY) | 02-Mar-09 | Market Purchase | 343 | $2.15 | $738.46 | < 1% 139.11K to 139.45K | 3246% |
| 06-Feb-09 6:37 PM View: | Allos Therapeutics, Inc. (ALTH) | 06-Feb-09 | Market Sale | 9,388 | $8.17 | $76,736.30 | (12%) 81.42K to 72.03K | 5% |
| 06-Feb-09 6:37 PM View: | Allos Therapeutics, Inc. (ALTH) | 05-Feb-09 | Market Sale | 4,646 | $8.14 | $37,827.70 | (5%) 86.07K to 81.42K | 4% |
| 06-Feb-09 6:37 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Feb-09 | Market Sale | 13,809 | $8.35 | $115,265.00 | (14%) 99.88K to 86.07K | 7% |
| 19-Dec-08 12:59 PM View: | Ardea Biosciences, Inc. (RDEA) | 19-Dec-08 | Market Purchase | 3,990 | $11.14 | $44,448.60 | 4% 91.66K to 95.65K | (16%) |
| 19-Dec-08 6:52 PM View: | Incyte Corp (INCY) | 19-Dec-08 | Market Purchase | 1,927 | $3.60 | $6,934.75 | 1% 137.18K to 139.11K | 1902% |
| 19-Dec-08 6:52 PM View: | Incyte Corp (INCY) | 18-Dec-08 | Market Purchase | 1,628 | $3.57 | $5,804.15 | 1% 135.56K to 137.18K | 1920% |
| 19-Dec-08 6:52 PM View: | Incyte Corp (INCY) | 17-Dec-08 | Market Purchase | 1,501 | $3.33 | $4,991.06 | 1% 134.05K to 135.56K | 2066% |
| 24-Nov-08 4:41 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 24-Nov-08 | Market Purchase | 49 | $0.98 | $47.91 | < 1% 27.28K to 27.33K | 663% |
| 24-Nov-08 4:41 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 21-Nov-08 | Market Purchase | 207 | $0.91 | $189.22 | < 1% 27.07K to 27.28K | 716% |
| 24-Nov-08 4:41 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Nov-08 | Market Purchase | 2,028 | $1.00 | $2,028.00 | 8% 25.04K to 27.07K | 646% |
| 21-Oct-08 7:41 PM View: | ViroPharma Inc. (VPHM) | 21-Oct-08 | Acquisition (other) | 98 | $2.74 | $268.52 | < 1% 74.98K to 75.08K | 358% |
| 05-Aug-08 9:09 AM View: | Incyte Corp (INCY) | 31-Jul-08 | Market Purchase | 4,997 | $9.00 | $44,973.00 | 4% 129.06K to 134.05K | 700% |
| 13-Nov-08 4:30 PM View: | Neurogen Corp. (NRGN) | 25-Jul-08 | Conversion | 125,112 | -- | -- | 59% 210.56K to 335.67K | |
| 16-May-08 5:55 PM View: | Ardea Biosciences, Inc. (RDEA) | 07-May-08 | Conversion | 42,089 | -- | -- | 79% 53.56K to 95.65K | |
| 14-Mar-08 5:55 PM View: | Seattle Genetics Inc. (SGEN) | 14-Mar-08 | Market Purchase | 583 | $8.07 | $4,707.46 | < 1% 365.06K to 365.64K | 766% |
| 14-Mar-08 5:55 PM View: | Seattle Genetics Inc. (SGEN) | 13-Mar-08 | Market Purchase | 181 | $7.93 | $1,434.44 | < 1% 364.88K to 365.06K | 782% |
| 14-Mar-08 5:55 PM View: | Seattle Genetics Inc. (SGEN) | 12-Mar-08 | Market Purchase | 55 | $7.98 | $438.99 | < 1% 364.83K to 364.88K | 776% |
| 27-Feb-08 5:17 PM View: | Allos Therapeutics, Inc. (ALTH) | 25-Feb-08 | Market Purchase | 425 | $6.00 | $2,550.00 | < 1% 99.45K to 99.88K | 30% |
| 21-Feb-08 5:47 PM View: | Allos Therapeutics, Inc. (ALTH) | 21-Feb-08 | Market Purchase | 617 | $6.04 | $3,729.70 | < 1% 98.84K to 99.45K | 29% |